Finny logo
Finny logo
Dibs:
Dibs:
0

Homology Medicines (FIXX) earnings: expect 22% revenue growth

12:51 pm ET, 09 May 2019

Homology Medicines (FIXX) is announcing earnings on May 13. We combed through analyst estimates to understand what the company revenue and earnings are predicted to look like.

What should you expect from the upcoming earnings?

Revenue for the next quarter is expected to be $1M, which implies a 22% growth rate year-over-year.

Earnings per share are expected to come in at $-0.55. If this materializes, EPS will grow 87% year-over-year.

How did the stock do last month?

Over the last month, Homology Medicines (FIXX) returned -23.25%.

What do analysts say about the stock?

Homology Medicines (FIXX) average analyst price target is 59.88% above its current price ($22.36).

For the latest price and information on Homology Medicines, please visit Finstead and ask for "FIXX", "FIXX analysis" or "FIXX news".

Homology Medicines Inc (FIXX) Stock Guide

Updated at: 11:10 am ET, 05 Sep 2020

Before we start: if you're looking for FIXX stock price, you can quickly find it out by visiting Finny and typing "FIXX quote". If you're looking for a quick scoop on FIXX stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "FIXX". You'll get all this info in one place. Or you can just type "FIXX news" to get the latest stock news.

Looking to buy or sell Homology Medicines Inc (FIXX)? Interested in getting the full scoop on FIXX, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this FIXX stock guide, we'll address key questions about FIXX, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are FIXX earnings?
2. When is FIXX earnings date?
3. FIXX buy or sell? What is FIXX Finny Score?
4. What are the reasons to buy FIXX? Why should I buy FIXX stock?
5. What are the reasons to sell FIXX? Why should I sell FIXX stock?
6. What are FIXX key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are FIXX earnings?

FIXX trailing 12-month earnings per share (EPS) is -$2.79.

2. When is FIXX earnings date?

FIXX earnings date is November 10, 2020.

Analysis

3. FIXX buy or sell? What is FIXX Finny Score?

#{finnyScore:50}Our quantitative analysis shows 4 reasons to buy and 4 reasons to sell FIXX, resulting in Finny Score of 50.

4. What are the reasons to buy FIXX? Why should I buy FIXX stock?

Here are the reasons to buy FIXX stock:

  • FIXX stock price ($11.01) is close to the 52-week low ($10.53). Perhaps now is a good time to buy? See FIXX price chart.
  • FIXX quarterly revenue growth was 44.60%, higher than the industry and sector average revenue growth (0.28% and 0.83%, respectively). See FIXX revenue growth chart.
  • FIXX PEG ratio (P/E adjusted for growth) is 0.36, which is low compared to its industry peers’ PEG ratios. See FIXX PEG chart.
  • FIXX cash to debt ratio is 12.45, higher than the average industry (0.16) and sector (0.16) cash to debt ratio. See FIXX cash to debt chart.

5. What are the reasons to sell FIXX? Why should I sell FIXX stock?

Let's look at the reasons to sell FIXX stock (i.e., the bear case):

Key Stats

6. What are FIXX key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for FIXX:

Metrics FIXX
Price $11.26
Average Price Target / Upside $29.56 / 162.52%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 124
Market Cap $475.24M
Forward P/E Ratio -3.54
Price/Book Ratio 220.12
Revenue (TTM) $2.16M
YoY Quarterly Revenue Growth 44.60%
Profit Margin 0.00%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us